Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 859817, 11 pages
http://dx.doi.org/10.1155/2014/859817
Review Article

Hematopoietic and Mesenchymal Stem Cells for the Treatment of Chronic Respiratory Diseases: Role of Plasticity and Heterogeneity

1Department of Medical and Surgical Sciences, University of Foggia, Viale L. Pinto 1, 71122 Foggia, Italy
2Medical Genetics Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Via Commenda 12, 20122 Milan, Italy

Received 29 August 2013; Accepted 20 October 2013; Published 19 January 2014

Academic Editors: N. C. Gorin, T. Liu, C. Porada, and V. J. Thannickal

Copyright © 2014 Massimo Conese et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. J. L. Murray and A. D. Lopez, “Alternative projections of mortality and disability by cause 1990–2020: global Burden of Disease Study,” The Lancet, vol. 349, no. 9064, pp. 1498–1504, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. P. J. Barnes, “Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease,” Journal of Allergy and Clinical Immunology, vol. 131, no. 3, pp. 636–645, 2013. View at Google Scholar
  3. F. Becq, “Cystic fibrosis transmembrane conductance regulator modulators for personalized drug treatment of cystic fibrosis: progress to date,” Drugs, vol. 70, no. 3, pp. 241–259, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. E. Grove, E. Bruscia, and D. S. Krause, “Plasticity of bone marrow-derived stem cells,” Stem Cells, vol. 22, no. 4, pp. 487–500, 2004. View at Google Scholar · View at Scopus
  5. J. A. Denburg and S. F. van Eeden, “Bone marrow progenitors in inflammation and repair: new vistas in respiratory biology and pathophysiology,” European Respiratory Journal, vol. 27, no. 3, pp. 441–445, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. D. J. Weiss, M. A. Berberich, Z. Borok et al., “Adult stem cells, lung biology, and lung disease,” Proceedings of the American Thoracic Society, vol. 3, no. 3, pp. 193–207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. B. N. Gomperts and R. M. Strieter, “Stem cells and chronic lung disease,” Annual Review of Medicine, vol. 58, pp. 285–298, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. J. Weiss, J. K. Kolls, L. A. Ortiz, A. Panoskaltsis-Mortari, and D. J. Prockop, “Stem cells and cell therapies in lung biology and lung diseases,” Proceedings of the American Thoracic Society, vol. 5, no. 5, pp. 637–667, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. V. Sueblinvong and D. J. Weiss, “Stem cells and cell therapy approaches in lung biology and diseases,” Translational Research, vol. 156, no. 3, pp. 188–205, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Pesci, B. Balbi, M. Majori et al., “Inflammatory cells and mediators in bronchial lavage of patients with chronic obstructive pulmonary disease,” European Respiratory Journal, vol. 12, no. 2, pp. 380–386, 1998. View at Google Scholar · View at Scopus
  11. P. J. Barnes, “Chronic obstructive pulmonary disease,” The New England Journal of Medicine, vol. 343, no. 4, pp. 269–280, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. B. M. Fischer, E. Pavlisko, and J. A. Voynow, “Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation,” International Journal of Chronic Obstructive Pulmonary Disease, vol. 6, pp. 413–421, 2011. View at Google Scholar · View at Scopus
  13. U. M. Sahiner, E. Birben, S. Erzurum, C. Sackesen, and O. Kalayci, “Oxidative stress in asthma,” World Allergy Organization Journal, vol. 4, no. 10, pp. 151–158, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. P. J. Barnes, “Pathophysiology of allergic inflammation,” Immunological Reviews, vol. 242, no. 1, pp. 31–50, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Aoshiba and A. Nagai, “Differences in airway remodeling between asthma and chronic obstructive pulmonary disease,” Clinical Reviews in Allergy and Immunology, vol. 27, no. 1, pp. 35–43, 2004. View at Google Scholar · View at Scopus
  16. M. H. Akabas, “Cystic fibrosis transmembrane conductance regulator. Structure and function of an epithelial chloride channel,” Journal of Biological Chemistry, vol. 275, no. 6, pp. 3729–3732, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. R. C. Boucher, “Cystic fibrosis: a disease of vulnerability to airway surface dehydration,” Trends in Molecular Medicine, vol. 13, no. 6, pp. 231–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. S. M. Rowe, S. Miller, and E. J. Sorscher, “Cystic fibrosis,” The New England Journal of Medicine, vol. 352, no. 19, pp. 1992–2001, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Hartl, P. Latzin, P. Hordijk et al., “Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease,” Nature Medicine, vol. 13, no. 12, pp. 1423–1430, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Conese, “Cystic fibrosis and the innate immune system: therapeutic implications,” Endocrine, Metabolic and Immune Disorders, vol. 11, no. 1, pp. 8–22, 2011. View at Google Scholar · View at Scopus
  21. A. Di, M. E. Brown, L. V. Deriy et al., “CFTR regulates phagosome acidification in macrophages and alters bactericidal activity,” Nature Cell Biology, vol. 8, no. 9, pp. 933–944, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Zhang, X. Li, H. Grassmé, G. Döring, and E. Gulbins, “Alterations in ceramide concentration and pH determine the release of reactive oxygen species by Cftr-deficient macrophages on infection,” Journal of Immunology, vol. 184, no. 9, pp. 5104–5111, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. T. N. Hilliard, N. Regamey, J. K. Shute et al., “Airway remodelling in children with cystic fibrosis,” Thorax, vol. 62, no. 12, pp. 1074–1080, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Ulrich, D. Worlitzsch, S. Viglio et al., “Alveolar inflammation in cystic fibrosis,” Journal of Cystic Fibrosis, vol. 9, no. 3, pp. 217–227, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Gaggar, A. Hector, P. E. Bratcher, M. A. Mall, M. Griese, and D. Hartl, “Series “matrix metalloproteinases in lung health and disease”: the role of matrix metalloproteinases in cystic fibrosis lung disease,” European Respiratory Journal, vol. 38, no. 3, pp. 721–727, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Krause, N. D. Theise, M. I. Collector et al., “Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell,” Cell, vol. 105, no. 3, pp. 369–377, 2001. View at Publisher · View at Google Scholar · View at Scopus
  27. A. P. Wong, A. E. Dutly, A. Sacher et al., “Targeted cell replacement with bone marrow cells for airway epithelial regeneration,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 293, no. 3, pp. L740–L752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. K. A. Tropea, E. Leder, M. Aslam et al., “Bronchioalveolar stem cells increase after mesenchymal stromal cell treatment in a mouse model of bronchopulmonary dysplasia,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 302, no. 9, pp. L829–L837, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. P. Eisenhauer, B. Earle, R. Loi et al., “Endogenous distal airway progenitor cells, lung mechanics, and disproportionate lobar growth following long-term postpneumonectomy in mice,” Stem Cells, vol. 31, no. 7, pp. 1330–1339, 2013. View at Google Scholar
  30. S. Abe, C. Boyer, X. Liu et al., “Cells derived from the circulation contribute to the repair of lung injury,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 11, pp. 1158–1163, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. N. D. Theise, O. Henegariu, J. Grove et al., “Radiation pneumonitis in mice: a severe injury model for pneumocyte engraftment from bone marrow,” Experimental Hematology, vol. 30, no. 11, pp. 1333–1338, 2002. View at Publisher · View at Google Scholar · View at Scopus
  32. J. E. Grove, C. Lutzko, J. Priller et al., “Marrow-derived cells as vehicles for delivery of gene therapy to pulmonary epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 27, no. 6, pp. 645–651, 2002. View at Google Scholar · View at Scopus
  33. V. B. Serikov, B. Popov, V. M. Mikhailov, N. Gupta, and M. A. Matthay, “Evidence of temporary airway epithelial repopulation and rare clonal formation by BM-derived cells following naphthalene injury in mice,” Anatomical Record, vol. 290, no. 9, pp. 1033–1045, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. B. T. Suratt, C. D. Cool, A. E. Serls et al., “Human pulmonary chimerism after hematopoietic stem cell transplantation,” American Journal of Respiratory and Critical Care Medicine, vol. 168, no. 3, pp. 318–322, 2003. View at Publisher · View at Google Scholar · View at Scopus
  35. J. Mattsson, M. Jansson, A. Wernerson, and M. Hassan, “Lung epithelial cells and type II pneumocytes of donor origin after allogeneic hematopoietic stem cell tansplantation,” Transplantation, vol. 78, no. 1, pp. 154–157, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. W. Kleeberger, A. Versmold, T. Rothämel et al., “Increased chimerism of bronchial and alveolar epithelium in human lung allografts undergoing chronic injury,” American Journal of Pathology, vol. 162, no. 5, pp. 1487–1494, 2003. View at Google Scholar · View at Scopus
  37. D. J. Weiss, I. Bertoncello, Z. Borok et al., “Stem cells and cell therapies in lung biology and lung diseases,” Proceedings of the American Thoracic Society, vol. 8, no. 3, pp. 223–272, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Aliotta, P. Keaney, M. Passero et al., “Bone marrow production of lung cells: the impact of G-CSF, cardiotoxin, graded doses of irradiation, and subpopulation phenotype,” Experimental Hematology, vol. 34, no. 2, pp. 230–241, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. E. L. Herzog, J. Van Arnam, B. Hu, and D. S. Krause, “Threshold of lung injury required for the appearance of marrow-derived lung epithelia,” Stem Cells, vol. 24, no. 8, pp. 1986–1992, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Conese, E. Copreni, D. Piro, and J. Rejman, “Gene and cell therapy for the treatment of cystic fibrosis,” Advances in Gene, Molecular and Cell Therapy, vol. 1, pp. 99–119, 2007. View at Google Scholar
  41. H. MacPherson, P. A. Keir, C. J. Edwards, S. Webb, and J. R. Dorin, “Following damage, the majority of bone marrow-derived airway cells express an epithelial marker,” Respiratory Research, vol. 7, article 145, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. M. Rojas, J. Xu, C. R. Woods et al., “Bone marrow-derived mesenchymal stem cells in repair of the injured lung,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 2, pp. 145–152, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. D. N. Kotton, B. Y. Ma, W. V. Cardoso et al., “Bone marrow-derived cells as progenitors of lung alveolar epithelium,” Development, vol. 128, no. 24, pp. 5181–5188, 2001. View at Google Scholar · View at Scopus
  44. D. N. Kotton, A. J. Fabian, and R. C. Mulligan, “Failure of bone marrow to reconstitute lung epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 4, pp. 328–334, 2005. View at Publisher · View at Google Scholar · View at Scopus
  45. A. J. Wagers, R. I. Sherwood, J. L. Christensen, and I. L. Weissman, “Little evidence for developmental plasticity of adult hematopoietic stem cells,” Science, vol. 297, no. 5590, pp. 2256–2259, 2002. View at Publisher · View at Google Scholar · View at Scopus
  46. J. C. Chang, R. Summer, X. Sun, K. Fitzsimmons, and A. Fine, “Evidence that bone marrow cells do not contribute to the alveolar epithelium,” American Journal of Respiratory Cell and Molecular Biology, vol. 33, no. 4, pp. 335–342, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. J. A. Fritzell Jr., Q. Mao, S. Gundavarapu et al., “Fate and effects of adult bone marrow cells in lungs of normoxic and hyperoxic newborn mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 5, pp. 575–587, 2009. View at Publisher · View at Google Scholar · View at Scopus
  48. P. J. Quesenberry, G. Colvin, G. Dooner, M. Dooner, J. M. Aliotta, and K. Johnson, “The stem cell continuum: cell cycle, injury, and phenotype lability,” Annals of the New York Academy of Sciences, vol. 1106, pp. 20–29, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. D. S. Krause, “Bone marrow-derived lung epithelial cells,” Proceedings of the American Thoracic Society, vol. 5, no. 6, pp. 699–702, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. S. H. Kassmer and D. S. Krause, “Detection of bone marrow-derived lung epithelial cells,” Experimental Hematology, vol. 38, no. 7, pp. 564–573, 2010. View at Publisher · View at Google Scholar · View at Scopus
  51. A.-L. Leblond, P. Naud, V. Forest et al., “Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury,” Human Gene Therapy, vol. 20, no. 11, pp. 1329–1343, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. J. Rejman, C. Colombo, and M. Conese, “Engraftment of bone marrow-derived stem cells to the lung in a model of acute respiratory infection by Pseudomonas aeruginosa,” Molecular Therapy, vol. 17, no. 7, pp. 1257–1265, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. Y. Jiang, B. N. Jahagirdar, R. L. Reinhardt et al., “Pluripotency of mesenchymal stem cells derived from adult marrow,” Nature, vol. 418, no. 6893, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  54. M. Kucia, R. Reca, V. R. Jala, B. Dawn, J. Ratajczak, and M. Z. Ratajczak, “Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells,” Leukemia, vol. 19, no. 7, pp. 1118–1127, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. M. Kucia, J. Ratajczak, and M. Z. Ratajczak, “Bone marrow as a source of circulating CXCR4+ tissue-committed stem cells,” Biology of the Cell, vol. 97, no. 2, pp. 133–146, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. B. N. Gomperts, J. A. Belperio, P. N. Rao et al., “Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury,” Journal of Immunology, vol. 176, no. 3, pp. 1916–1927, 2006. View at Google Scholar · View at Scopus
  57. R. G. Harris, E. L. Herzog, E. M. Bruscia, J. E. Grove, J. S. Van Arnam, and D. S. Krause, “Lack of a fusion requirement for development of bone marrow-derived epithelia,” Science, vol. 305, no. 5680, pp. 90–93, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. M. Alvarez-Dolado, R. Pardal, J. M. Garcia-Verdugo et al., “Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes,” Nature, vol. 425, no. 6961, pp. 968–973, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. E. L. Herzog, J. Van Arnam, B. Hu et al., “Lung-specific nuclear reprogramming is accompanied by heterokaryon formation and Y chromosome loss following bone marrow transplantation and secondary inflammation,” FASEB Journal, vol. 21, no. 10, pp. 2592–2601, 2007. View at Publisher · View at Google Scholar · View at Scopus
  60. J. M. Aliotta, F. M. Sanchez-Guijo, G. J. Dooner et al., “Alteration of marrow cell gene expression, protein production, and engraftment into lung by lung-derived microvesicles: a novel mechanism for phenotype modulation,” Stem Cells, vol. 25, no. 9, pp. 2245–2256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  61. J. M. Aliotta, M. Pereira, K. W. Johnson et al., “Microvesicle entry into marrow cells mediates tissue-specific changes in mRNA by direct delivery of mRNA and induction of transcription,” Experimental Hematology, vol. 38, no. 3, pp. 233–245, 2010. View at Publisher · View at Google Scholar · View at Scopus
  62. A. N. Lau, M. Goodwin, C. F. Kim, and D. J. Weiss, “Stem cells and regenerative medicine in lung biology and diseases,” Molecular Therapy, vol. 20, no. 6, pp. 1116–1130, 2012. View at Google Scholar
  63. M. Conese, A. Carbone, S. Castellani, and S. Di Gioia, “Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases,” Cells Tissues Organs, vol. 197, no. 6, pp. 445–473, 2013. View at Google Scholar
  64. M. Yamada, H. Kubo, S. Kobayashi et al., “Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury,” Journal of Immunology, vol. 172, no. 2, pp. 1266–1272, 2004. View at Google Scholar · View at Scopus
  65. X.-X. Wang, F.-R. Zhang, Y.-P. Shang et al., “Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension. A pilot randomized controlled trial,” Journal of the American College of Cardiology, vol. 49, no. 14, pp. 1566–1571, 2007. View at Publisher · View at Google Scholar · View at Scopus
  66. J. H. Zhu, X. X. Wang, F. R. Zhang et al., “Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: open-label pilot study,” Pediatric Transplantation, vol. 12, no. 6, pp. 650–655, 2008. View at Publisher · View at Google Scholar · View at Scopus
  67. G.-P. Diller, T. Thum, M. R. Wilkins, and J. Wharton, “Endothelial progenitor cells in pulmonary arterial hypertension,” Trends in Cardiovascular Medicine, vol. 20, no. 1, pp. 22–29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  68. R. J. Phillips, M. D. Burdick, K. Hong et al., “Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis,” Journal of Clinical Investigation, vol. 114, no. 3, pp. 438–446, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. M. W. Epperly, H. Guo, J. E. Gretton, and J. S. Greenberger, “Bone marrow origin of myofibroblasts in irradiation pulmonary fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 29, no. 2, pp. 213–224, 2003. View at Publisher · View at Google Scholar · View at Scopus
  70. N. Hashimoto, H. Jin, T. Liu, S. W. Chensue, and S. H. Phan, “Bone marrow-derived progenitor cells in pulmonary fibrosis,” Journal of Clinical Investigation, vol. 113, no. 2, pp. 243–252, 2004. View at Publisher · View at Google Scholar · View at Scopus
  71. B. B. Moore, J. E. Kolodsick, V. J. Thannickal et al., “CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury,” American Journal of Pathology, vol. 166, no. 3, pp. 675–684, 2005. View at Google Scholar · View at Scopus
  72. H. Tanjore, X. C. Xu, V. V. Polosukhin et al., “Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis,” American Journal of Respiratory and Critical Care Medicine, vol. 180, no. 7, pp. 657–665, 2009. View at Publisher · View at Google Scholar · View at Scopus
  73. R. M. Strieter, E. C. Keeley, M. D. Burdick, and B. Mehrad, “The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis,” Transactions of the American Clinical and Climatological Association, vol. 120, pp. 49–59, 2009. View at Google Scholar · View at Scopus
  74. E. C. Keeley, B. Mehrad, and R. M. Strieter, “Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis,” International Journal of Biochemistry and Cell Biology, vol. 42, no. 4, pp. 535–542, 2010. View at Publisher · View at Google Scholar · View at Scopus
  75. B. N. Gomperts and R. M. Strieter, “Fibrocytes in lung disease,” Journal of Leukocyte Biology, vol. 82, no. 3, pp. 449–456, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. A. Bellini and S. Mattoli, “The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses,” Laboratory Investigation, vol. 87, no. 9, pp. 858–870, 2007. View at Publisher · View at Google Scholar · View at Scopus
  77. L. A. Ortiz, F. Gambelli, C. McBride et al., “Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8407–8411, 2003. View at Publisher · View at Google Scholar · View at Scopus
  78. N. Gupta, X. Su, B. Popov, W. L. Jae, V. Serikov, and M. A. Matthay, “Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin-induced acute lung injury in mice,” Journal of Immunology, vol. 179, no. 3, pp. 1855–1863, 2007. View at Google Scholar · View at Scopus
  79. J. Xu, C. R. Woods, A. L. Mora et al., “Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice,” American Journal of Physiology—Lung Cellular and Molecular Physiology, vol. 293, no. 1, pp. L131–L141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  80. L. A. Ortiz, M. DuTreil, C. Fattman et al., “Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 26, pp. 11002–11007, 2007. View at Publisher · View at Google Scholar · View at Scopus
  81. G. Chamberlain, J. Fox, B. Ashton, and J. Middleton, “Concise review: mesenchymal stem cells: their phenotype, differentiation capacity, immunological features, and potential for homing,” Stem Cells, vol. 25, no. 11, pp. 2739–2749, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. I. Rasmusson, “Immune modulation by mesenchymal stem cells,” Experimental Cell Research, vol. 312, no. 12, pp. 2169–2179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. M. M. Duffy, T. Ritter, R. Ceredig, and M. D. Griffin, “Mesenchymal stem cell effects on T-cell effector pathways,” Stem Cell Research and Therapy, vol. 2, no. 4, article 34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. F. Bifari, V. Lisi, E. Mimiola, A. Pasini, and M. Krampera, “Immune modulation by mesenchymal stem cells,” Transfusion Medicine and Hemotherapy, vol. 35, no. 3, pp. 194–204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  85. K. Le Blanc, F. Frassoni, L. Ball et al., “Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study,” The Lancet, vol. 371, no. 9624, pp. 1579–1586, 2008. View at Publisher · View at Google Scholar · View at Scopus
  86. M. Duijvestein, A. C. W. Vos, H. Roelofs et al., “Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I study,” Gut, vol. 59, no. 12, pp. 1662–1669, 2010. View at Publisher · View at Google Scholar · View at Scopus
  87. H. K. Salem and C. Thiemermann, “Mesenchymal stromal cells: current understanding and clinical status,” Stem Cells, vol. 28, no. 3, pp. 585–596, 2010. View at Publisher · View at Google Scholar · View at Scopus
  88. S. C. Abreu, M. A. Antunes, P. Pelosi, M. M. Morales, and P. R. M. Rocco, “Mechanisms of cellular therapy in respiratory diseases,” Intensive Care Medicine, vol. 37, no. 9, pp. 1421–1431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  89. C. A. de Faria, R. de las Heras Kozma, T. Stessuk, and J. T. Ribeiro-Paes, “Experimental basis and new insights for cell therapy in chronic obstructive pulmonary disease,” Stem Cell Reviews, vol. 8, no. 4, pp. 1236–1244, 2012. View at Google Scholar
  90. R. Loi, T. Beckett, K. K. Goncz, B. T. Suratt, and D. J. Weiss, “Limited restoration of cystic fibrosis lung epithelium in vivo with adult bone marrow-derived cells,” American Journal of Respiratory and Critical Care Medicine, vol. 173, no. 2, pp. 171–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  91. E. M. Bruscia, E. C. Ziegler, J. E. Price, S. Weiner, M. E. Egan, and D. S. Krause, “Engraftment of donor-derived epithelial cells in multiple organs following bone marrow transplantation into newborn mice,” Stem Cells, vol. 24, no. 10, pp. 2299–2308, 2006. View at Publisher · View at Google Scholar · View at Scopus
  92. E. M. Bruscia, J. E. Price, E.-C. Cheng et al., “Assessment of cystic fibrosis transmembrane conductance regulator (CFTR) activity in CFTR-null mice after bone marrow transplantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 8, pp. 2965–2970, 2006. View at Publisher · View at Google Scholar · View at Scopus
  93. C. Agostini, “Stem cell therapy for chronic lung diseases: hope and reality,” Respiratory Medicine, vol. 104, no. 1, pp. S86–S91, 2010. View at Publisher · View at Google Scholar · View at Scopus
  94. J. T. Ribeiro-Paes, A. Bilaqui, O. T. Greco et al., “Unicentric study of cell therapy in chronic obstructive pulmonary disease/pulmonary emphysema,” International Journal of COPD, vol. 6, no. 1, pp. 63–71, 2011. View at Publisher · View at Google Scholar · View at Scopus
  95. D. J. Weiss, R. Casaburi, R. Flannery, M. Leroux-Williams, and D. P. Tashkin, “A placebo-controlled randomized trial of mesenchymal stem cells in chronic obstructive pulmonary disease,” Chest, vol. 143, no. 6, pp. 1590–1598, 2013. View at Publisher · View at Google Scholar
  96. G. J. Spangrude and G. R. Johnson, “Resting and activated subsets of mouse multipotent hematopoietic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 87, no. 19, pp. 7433–7437, 1990. View at Google Scholar · View at Scopus
  97. R. J. Jones, M. I. Collector, J. P. Barber et al., “Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity,” Blood, vol. 88, no. 2, pp. 487–491, 1996. View at Google Scholar · View at Scopus
  98. C. T. Jordan, G. Yamasaki, and D. Minamoto, “High-resolution cell cycle analysis of defined phenotypic subsets within primitive human hematopoietic cell populations,” Experimental Hematology, vol. 24, no. 11, pp. 1347–1355, 1996. View at Google Scholar · View at Scopus
  99. N. Uchida, L. Jerabek, and I. L. Weissman, “Searching for hematopoietic stem cells. II. The heterogeneity of Thy-1.1(lo)Lin(-/lo)Sca-1+ mouse hematopoietic stem cells separated by counterflow centrifugal elutriation,” Experimental Hematology, vol. 24, no. 5, pp. 649–659, 1996. View at Google Scholar · View at Scopus
  100. M. A. Goodell, M. Rosenzweig, H. Kim et al., “Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species,” Nature Medicine, vol. 3, no. 12, pp. 1337–1345, 1997. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Gothot, R. Pyatt, J. McMahel, S. Rice, and E. F. Srour, “Functional heterogeneity of human CD34+ cells isolated in subcompartments of the G0/G1 phase of the cell cycle,” Blood, vol. 90, no. 11, pp. 4384–4393, 1997. View at Google Scholar · View at Scopus
  102. A. Gothot, R. Pyatt, J. McMahel, S. Rice, and E. F. Srour, “Assessment of proliferative and colony-forming capacity after successive in vitro divisions of single human CD34+ cells initially isolated in G0,” Experimental Hematology, vol. 26, no. 7, pp. 562–570, 1998. View at Google Scholar · View at Scopus
  103. A. Wiesmann, R. L. Phillips, M. Mojica et al., “Expression of CD27 on murine hematopoietic stem and progenitor cells,” Immunity, vol. 12, no. 2, pp. 193–199, 2000. View at Google Scholar · View at Scopus
  104. B. Dykstra, D. Kent, M. Bowie et al., “Long-term propagation of distinct hematopoietic differentiation programs in vivo,” Cell Stem Cell, vol. 1, no. 2, pp. 218–229, 2007. View at Publisher · View at Google Scholar · View at Scopus
  105. D. G. Kent, M. R. Copley, C. Benz et al., “Prospective isolation and molecular characterization of hematopoietic stem cells with durable self-renewal potential,” Blood, vol. 113, no. 25, pp. 6342–6350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  106. H. B. Sieburg, R. H. Cho, B. Dykstra, N. Uchida, C. J. Eaves, and C. E. Muller-Sieburg, “The hematopoietic stem compartment consists of a limited number of discrete stem cell subsets,” Blood, vol. 107, no. 6, pp. 2311–2316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  107. P. Benveniste, C. Frelin, S. Janmohamed et al., “Intermediate-term hematopoietic stem cells with extended but time-limited reconstitution potential,” Cell Stem Cell, vol. 6, no. 1, pp. 48–58, 2010. View at Publisher · View at Google Scholar · View at Scopus
  108. I. R. Lemischka, R. H. Raulet, and R. C. Mulligan, “Developmental potential and dynamic behavior of hematopoietic stem cells,” Cell, vol. 45, no. 6, pp. 917–927, 1986. View at Google Scholar · View at Scopus
  109. G. A. Challen, N. C. Boles, S. M. Chambers, and M. A. Goodell, “Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-β1,” Cell Stem Cell, vol. 6, no. 3, pp. 265–278, 2010. View at Publisher · View at Google Scholar · View at Scopus
  110. T. Schroeder, “Hematopoietic stem cell heterogeneity: subtypes, not unpredictable behavior,” Cell Stem Cell, vol. 6, no. 3, pp. 203–207, 2010. View at Publisher · View at Google Scholar · View at Scopus
  111. M. A. Cross, C. M. Heyworth, A. M. Murrell, E. O. Bockamp, T. M. Dexter, and A. R. Green, “Expression of lineage restricted transcription factors precedes lineage specific differentiation in a multipotent haemopoietic progenitor cell line,” Oncogene, vol. 9, no. 10, pp. 3013–3016, 1994. View at Google Scholar · View at Scopus
  112. H. H. Chang, M. Hemberg, M. Barahona, D. E. Ingber, and S. Huang, “Transcriptome-wide noise controls lineage choice in mammalian progenitor cells,” Nature, vol. 453, no. 7194, pp. 544–547, 2008. View at Publisher · View at Google Scholar · View at Scopus
  113. T. Graf and T. Enver, “Forcing cells to change lineages,” Nature, vol. 462, no. 7273, pp. 587–594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  114. T. Schroeder, “Long-term single-cell imaging of mammalian stem cells,” Nature Methods, vol. 8, no. 4, pp. S30–S35, 2011. View at Publisher · View at Google Scholar · View at Scopus
  115. K. Hope and M. Bhatia, “Clonal interrogation of stem cells,” Nature Methods, vol. 8, no. 4, pp. S36–S40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  116. D. G. Phinney, “Biochemical heterogeneity of mesenchymal stem cell populations: clues to their therapeutic efficacy,” Cell Cycle, vol. 6, no. 23, pp. 2884–2889, 2007. View at Google Scholar · View at Scopus
  117. K. C. Russell, D. G. Phinney, M. R. Lacey, B. L. Barrilleaux, K. E. Meyertholen, and K. C. O'Connor, “In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment,” Stem Cells, vol. 28, no. 4, pp. 788–798, 2010. View at Publisher · View at Google Scholar · View at Scopus
  118. K. C. Russell, M. R. Lacey, J. K. Gilliam, H. A. Tucker, D. G. Phinney, and K. C. O'Connor, “Clonal analysis of the proliferation potential of human bone marrow mesenchymal stem cells as a function of potency,” Biotechnology and Bioengineering, vol. 108, no. 11, pp. 2716–2726, 2011. View at Publisher · View at Google Scholar · View at Scopus
  119. A. P. Wong, A. Keating, W.-Y. Lu et al., “Identification of a bone marrow-derived epithelial-like population capable of repopulating injured mouse airway epithelium,” Journal of Clinical Investigation, vol. 119, no. 2, pp. 336–348, 2009. View at Publisher · View at Google Scholar · View at Scopus
  120. M. Kucia, M. Wysoczynski, J. Ratajczak, and M. Z. Ratajczak, “Identification of very small embryonic like (VSEL) stem cells in bone marrow,” Cell and Tissue Research, vol. 331, no. 1, pp. 125–134, 2008. View at Publisher · View at Google Scholar · View at Scopus
  121. J. Ratajczak, M. Wysoczynski, E. Zuba-Surma et al., “Adult murine bone marrow-derived very small embryonic-like stem cells differentiate into the hematopoietic lineage after coculture over OP9 stromal cells,” Experimental Hematology, vol. 39, no. 2, pp. 225–237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  122. M. Dominici, C. Pritchard, J. E. Garlits, T. J. Hofmann, D. A. Persons, and E. M. Horwitz, “Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 32, pp. 11761–11766, 2004. View at Publisher · View at Google Scholar · View at Scopus
  123. E. A. Olmsted-Davis, Z. Gugala, F. Camargo et al., “Primitive adult hematopoietic stem cells can function as osteoblast precursors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 26, pp. 15877–15882, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. S. H. Kassmer, E. M. Bruscia, P.-X. Zhang, and D. S. Krause, “Nonhematopoietic cells are the primary source of bone marrow-derived lung epithelial cells,” Stem Cells, vol. 30, no. 3, pp. 491–499, 2012. View at Publisher · View at Google Scholar · View at Scopus
  125. S. H. Kassmer, H. Jin, P. X. Zhang et al., “Very small embryonic-like stem cells from the murine bone marrow differentiate into epithelial cells of the lung,” Stem Cells, vol. 31, no. 12, pp. 2759–2766, 2013. View at Publisher · View at Google Scholar
  126. M. Kucia, R. Reca, F. R. Campbell et al., “A population of very small embryonic-like (VSEL) CXCR4+ SSEA-1+Oct-4+ stem cells identified in adult bone marrow,” Leukemia, vol. 20, no. 5, pp. 857–869, 2006. View at Publisher · View at Google Scholar · View at Scopus
  127. F. Anjos-Afonso and D. Bonnet, “Nonhematopoietic/endothelial SSEA-1+ cells define the most primitive progenitors in the adult murine bone marrow mesenchymal compartment,” Blood, vol. 109, no. 3, pp. 1298–1306, 2007. View at Publisher · View at Google Scholar · View at Scopus
  128. D. Piro, C. Piccoli, L. Guerra et al., “Hematopoietic stem/progenitor cells express functional mitochondrial energy-dependent cystic fibrosis transmembrane conductance regulator,” Stem Cells and Development, vol. 21, no. 4, pp. 634–646, 2012. View at Publisher · View at Google Scholar · View at Scopus
  129. K. Akashi, D. Traver, T. Miyamoto, and I. L. Weissman, “A clonogenic common myeloid progenitor that gives rise to all myeloid lineages,” Nature, vol. 404, no. 6774, pp. 193–197, 2000. View at Publisher · View at Google Scholar · View at Scopus
  130. M. Kondo, I. L. Weissman, and K. Akashi, “Identification of clonogenic common lymphoid progenitors in mouse bone marrow,” Cell, vol. 91, no. 5, pp. 661–672, 1997. View at Google Scholar · View at Scopus
  131. C. Piccoli, R. Ria, R. Scrima et al., “Characterization of mitochondrial and extra-mitochondrial oxygen consuming reactions in human hematopoietic stem cells: novel evidence of the occurrence of NAD(P)H oxidase activity,” Journal of Biological Chemistry, vol. 280, no. 28, pp. 26467–26476, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. T. Trotta, S. Di Gioia, D. Piro et al., “Effect of acute lung injury on VLA-4 and CXCR4 expression in resident and circulating hematopoietic stem/progenitor cells,” Respiration, vol. 85, no. 3, pp. 252–264, 2013. View at Google Scholar
  133. P. J. Quesenberry, “The continuum model of marrow stem cell regulation,” Current Opinion in Hematology, vol. 13, no. 4, pp. 216–221, 2006. View at Publisher · View at Google Scholar · View at Scopus
  134. G. A. Colvin, M. S. Dooner, G. J. Dooner et al., “Stem cell continuum: directed differentiation hotspots,” Experimental Hematology, vol. 35, no. 1, pp. 96–107, 2007. View at Publisher · View at Google Scholar · View at Scopus
  135. M. S. Dooner, J. M. Aliotta, J. Pimentel et al., “Conversion potential of marrow cells into lung cells fluctuates with cytokine-induced cell cycle,” Stem Cells and Development, vol. 17, no. 2, pp. 207–219, 2008. View at Publisher · View at Google Scholar · View at Scopus
  136. J. Xu, A. Mora, H. Shim, A. Stecenko, K. L. Brigham, and M. Rojas, “Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis,” American Journal of Respiratory Cell and Molecular Biology, vol. 37, no. 3, pp. 291–299, 2007. View at Publisher · View at Google Scholar · View at Scopus
  137. L. A. May, A. Kicic, P. Rigby et al., “Cells of epithelial lineage are present in blood, engraft the bronchial epithelium, and are increased in human lung transplantation,” Journal of Heart and Lung Transplantation, vol. 28, no. 6, pp. 550–557, 2009. View at Publisher · View at Google Scholar · View at Scopus
  138. E. M. Bruscia, P.-X. Zhang, E. Ferreira et al., “Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/-mice,” American Journal of Respiratory Cell and Molecular Biology, vol. 40, no. 3, pp. 295–304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  139. C. Bonini, G. Ferrari, S. Verzeletti et al., “HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia,” Science, vol. 276, no. 5319, pp. 1719–1724, 1997. View at Publisher · View at Google Scholar · View at Scopus
  140. S. Mastaglio, M. T. L. Stanghellini, C. Bordignon, A. Bondanza, F. Ciceri, and C. Bonini, “Progress and prospects: graft-versus-host disease,” Gene Therapy, vol. 17, no. 11, pp. 1309–1317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  141. F. Zhao, Y. F. Zhang, Y. G. Liu et al., “Therapeutic effects of bone marrow-derived mesenchymal stem cells engraftment on bleomycin-induced lung injury in rats,” Transplantation Proceedings, vol. 40, no. 5, pp. 1700–1705, 2008. View at Publisher · View at Google Scholar · View at Scopus